Botulinum toxin type A for facial wrinkles-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Botulinum toxin type A for facial wrinkles

Published:2021-07-05 Issue:1 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Camargo Cristina Pires¹,Xia Jun²,Costa Caroline S³,Gemperli Rolf⁴,Tatini Maria DC⁵,Bulsara Max K⁶⁷⁸,Riera Rachel⁹

Affiliation:

1. Laboratory of Microsurgery and Plastic Surgery (LIM-04), School of Medicine; Universidade de São Paulo; São Paulo Brazil

2. Nottingham China Health Institute; The University of Nottingham Ningbo; Ningbo China

3. Department of Specialised Medicine, Discipline of Dermatology; Universidade Federal do Piaui; Teresina Brazil

4. Department of Surgery, Discipline of Plastic Surgery; Universidade de São Paulo; São Paulo Brazil

5. c/o Cochrane Skin Group; The University of Nottingham; Nottingham UK

6. Institute for Health Research; University of Notre Dame Australia; Fremantle Australia

7. School of Population and Global Health; The University of Western Australia; Perth Australia

8. Division of Surgery and Interventional Science; University College London; London UK

9. Cochrane Brazil Rio de Janeiro; Cochrane; Petrópolis Brazil

Publisher

Wiley

Subject

Pharmacology (medical)

Reference145 articles.

1. A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines;Ascher;Journal of the American Academy of Dermatology,2004

2. Botulinum toxin A in the treatment of glabellar lines: scheduling the next injection;Ascher;Aesthetic Surgery Journal,2005

3. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study;Ascher;Dermatologic Surgery,2009

4. Liquid formulation of abobotulinumtoxinA exhibits a favorable efficacy and safety profile in moderate to severe glabellar lines: a randomized, double-blind, placebo- and active comparator-controlled trial;Ascher;Aesthetic Surgery Journal,2018

5. Liquid formulation of abobotulinumtoxinA: A 6-month, phase 3, double-blind,randomized, placebo-controlled study of a single treatment, ready-to-use toxin for moderate-to-severe glabellar lines;Ascher;Aesthetic Surgery Journal,2020

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Botulinum toxin type A inhibits the formation of hypertrophic scar through the JAK2/STAT3 pathway;Biomolecules and Biomedicine;2024-08-10

2. Temporary Delayed Hypersensitivity Reaction to Botulinum Toxin-A After COVID-19 Vaccination: A Case Series;Aesthetic Plastic Surgery;2024-07-24

3. The Role of Botulinum Toxin A Neuromodulator in the Management of Synkinesis in Facial Palsy;Facial Plastic Surgery;2024-07-22

4. Assessment of the Efficacy and Durability of IncobotulinumtoxinA in the Treatment of the Upper Face in Adult Women;Dermatology and Therapy;2024-07-02

5. LetibotulinumtoxinA Attenuates the Psychological Burden of Glabellar Lines and Is Associated With High Subject Satisfaction in Phase 3 Clinical Trials;Dermatologic Surgery;2024-03-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3